Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-20-064624)

Filing Details

Accession Number:: 0001209191-20-064624
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-12-21 16:15:11
Reporting Period:: 2020-12-18

Accepted Time:: 2020-12-21 16:15:11
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
907654	Arca Biopharma Inc.	ABIO	In Vitro & In Vivo Diagnostic Substances (2835)	363855489

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1184334	E Robert Conway	10170 Church Ranch Way Suite 100 Westminster CO 80021		Yes	No	No	Yes

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-12-18	10,000	$4.16	30,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from$4.1497 to $4.1696. Upon request of the SEC staff, ARCA biopharma, Inc. (the "Company") or a security holder of the Company, the reporting personwill provide full information regarding the number of shares purchased at each separate price.